Alternative use of botulinum toxin in urology

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 5, 2004, Pages 1015-1021

  Maan, Zaf ^a   Al Singary, Waleed ^b   Shergill, Iqbal ^c   Joseph, Joseph V ^e   Arya, Manit ^d   Patel, Hitendra R H ^e  

^a EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b WORTHING HOSPITAL   (United Kingdom)

^c INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Botulinum toxin; Detrusor hyper reflexia (neurogenic detrusor overactivity); Detrusor sphincter dysynergia; Neurogenic bladder; Pelvic pain; Prostatitis; Spinal cord injury

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CAPSAICIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; LIDOCAINE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PHENOL; SPASMOLYTIC AGENT;

BLADDER CATHETERIZATION; BLADDER OBSTRUCTION; BLADDER SPHINCTER; CLINICAL TRIAL; DETRUSOR DYSSYNERGIA; DRUG TOLERABILITY; DYSPHAGIA; FEVER; HUMAN; HYPERREFLEXIA; INTERSTITIAL CYSTITIS; MUSCLE DENERVATION; MUSCLE WEAKNESS; MYOMECTOMY; NAUSEA; NEUROGENIC BLADDER; PELVIS PAIN SYNDROME; PROSTATE HYPERTROPHY; RESPIRATORY TRACT DISEASE; REVIEW; SPHINCTEROTOMY; STRESS INCONTINENCE; URGE INCONTINENCE; URINARY TRACT DISEASE; URINE RETENTION; UROLOGY; VOMITING; XEROSTOMIA;

BOTULINUM TOXINS; HUMANS; MULTICENTER STUDIES; MUSCLE HYPERTONIA; RETROSPECTIVE STUDIES; UROLOGIC DISEASES;

EID: 2542594068     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.5.1015     Document Type: Review

References (44)

1. SCOTT AB: Botulinum toxin injection of eye muscles to correct strabismus. Trans. Am. Ophthalmol. Soc. (1981) 79:734.
2. NEUMANN M, WOLFGANG HJ, TOYKA KV: Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. Arch. Neurol. (1999) 56:914-916.
3. VERHEYDEN J,BLITZER A, BRIN MF: Other non cosmetic uses of BOTOX. Semin. Cutan. Med. Surg. (2001) 20(2):121-126.
4. LEIPPOLD T, REITZ A, SCHURCH B: Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur. Urol. (2003) 44:165-174.
5. SLOOP RR, COLE BA, ESCUTIN RO: Human response to botulinum toxin injection: type B compared to type A. Neurology (1997) 49(1):189-194.
6. BARNES M: Botulinum toxin - mechanisms of action and clinical use in spasticity. J. Rehabil. Med. (2003) 41 (Suppl.): 56-59.
7. WHEELER JS Jr, WALTER JS, CHINTAM RS et al.: Botulinum toxin injections for voiding dysfunction following SCI. J. Spinal Cord Med. (1988) 21:227-229.
8. DUCHEN LW: Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles. J. Neurol. Neurosurg. Psychiatry (1970) 33:40.
9. BORODIC GE, JOSEPH M, FAY L et al.: Botulinum toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck (1990) 12:392.
10. LAZZERI M: New pharmaological tools. Urodynamica (2003) 13:67-73.
11. NOLAN J, CHALKIADIS GA, LOW J et al.: Anaesthesia and pain management in cerebral palsy. Anaesthesia (2000) 55:32-41.
12. SCHURCH B, HAURI D, RODIC B: Botulinum-A toxin as a treatment of detrusor-sphiincter dyssynergia: a prospective study in 24 spinal cord injury patients. J. Urol. (1996) 155:1023-1029.
13. DESEZE M, PETIT H, GALLIEN P et al.: Botulinum A toxin and detrusor sphincter dyssynergia: a double blind lidocaine controlled study in 13 patients with spinal cord disease. Eur. Urol. (2002) 42:56-62.
14. PHELAN MW, FRANKS M, SOMOGYI GT et al.: Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J. Urol. (2001) 165:1107-1110.
15. DYKSTRA D, SIDI A, SCOTT B et al.: Effects of botulinum toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J. Urol. (1988) 139:919-922.
16. DYKSTRA D, SIDI A: Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double blind study. Arch. Phys. Med. Rehabil. (1990) 71:24-26.
17. GALLIEN P, ROBINEAU S, VERIN M et al.: Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin. Arch. Phys. Med. Rehabil. (1998) 79:715-717.
18. PLEVNIK S, JANEZ J: Maximal electrical stimulation for urinary incontinence: report of 98 cases. Urology (1979) 14(6):638-645.
19. LITWILLER SE, FROHMAN EM, ZIMMERN P: Multiple sclerosis and the urologist. J. Urol. (1999) 161:743-757.
20. SCHURCH B, STOHRER M, KRAMER D: Botulinum A toxin for treating detrusor hyperreflaxia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J. Urol. (2000) 164:692-697.
21. SCHULTE-BAUKLOH H, MICHAEL T, SCHOBERT J: Efficacy of botulinum A toxin in children with detrusor hyperreflexia due to myelomeningocele: Preliminary results. Urology (2002) 59(3):325-328.
22. ELLIOT DS, BOONE TB: Recent advances in the management of the neurogenic bladder. Urology (2000) 56(Suppl. 6A):76-81.
23. SCHURCH B, SCHMID DM, STOHRER M: Treatment of neurogenic incontinence with botulinum toxin A [correspondence]. N. Engl. J. Med. (2000) 342(9):665.
24. REITZ A, STOHRER M, KRAMER G et al.: European Experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur. Urol. (2004) 45(4):510-515.
25. MALL V, GLOCKER FX, FRANKENSCHMIDT A et al.: Treatment of neuropathic bladder using botulinum toxin A in a 1 year old child with myelomeningocele. Paediatr. Nephrol. (2001) 16:1161-1162.
26. MARIA G, DESTITO A, LACQUANTI S: Relief by botulinum toxin of voiding dysfunction due to prostatitis. Lancet (1998) 352:625.
27. ZERMANN DH, ISHIGOOKA M, DOGGWEILER-WIYGUL R et al.: Perisphincteric injection of botulinum toxin type A. A treatment option in patients with chronic prostatic pain? Eur. Urol. (2000) 38(4):393-399.
28. YOKOYAMA T, KUMON H, SMITH CP et al.: Botulinum toxin treatment of urethral and bladder dysfunction. Acta Med. Okayama. (2002) 56(6):271-277.
29. FOWLER CF, BETTS CD, CHRISTMAS TJ et al.: Botulinum toxin in the treatment of chronic urinary retention in women. Br. J. Urol. (1992) 70:387-389.
30. KUO H: Effect of botulinum A toxin in the treatment of voiding dysfunction due to detrusor underactivity. Urology (2003) 61(3):550-554.
31. MARIA G, BRISINDA G, CIVELLO IM et al.: Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo controlled study. Urology (2003) 62(2):259-264.
32. BORODIC GE AND PEARCE L: New concepts in botulinum toxin therapy. Drug Saf. (1994) 11(3):145-152.
33. BOYD RN, BRITTON TC, ROBINSON RO et al.: Transient urinary incontinence after botulinum A toxin. Lancet (1996) 348:481.
34. WYNDAELE JJ, VAN DROMME SA: Muscular weakness as a side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord (2002) 40(11):599-600.
35. KUMAR V, TEMPLEMAN L, CHAPPLE CR: Recent developments in the management of detrusor overactivity. Curr. Opin. Urol. (2003) 13(4):285-291.
36. FOWLER CJ: Urinary retention in women. Br. J. Urol. (2003) 91:463-464.
37. HARPER M, POPAT RB, DASGUPTA R et al.: A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. Br. J. Urol. (2003) 92(3):325-326.
38. KUO H: Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J. Urol. (2003) 170(5):1908-1912.
39. SMITH CP, FRANKS ME, MCNEIL BK et al.: Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J. Urol. (2003) 169(5):1896-1900.
40. DYKSTRA DD, PRYOR J, GOLDISH G: Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report. Arch. Phys. Med. Rehabil. (2003) 84(9):1399-1400.
41. DYKSTRA D, ENRIQUEZ A, VALLEY M: Treatment of overactive bladder with botulinum toxin type B: a pilot study. Int. Urogynecol. J. Pelvic Floor Dysfunct. (2003) 14(6):424-426.
42. DRESSLER D: Botulinum Toxin type B: where do we stand? Eur. Neurol. (2001) 46:113-114.
43. REITZ A, SCHURCH B: Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. J. Urol. (2004) 171:804-805.
44. PISTOLESI D, SELLI B, ROSSI B et al.: Botulinum toxin type B for type A resistant bladder spasticity. J. Urol. (2004) 171:802-803.